drugset / Trial / NCT04931615

ARTISS a Single-centre Randomised Control Study

NCT04931615 ↗

Phase 4 Completed 135 enrolled Mid and South Essex NHS Foundation Trust
RandomizedParallel-groupDouble-blindTreatment

Summary

The Influence of ARTISS on post-operative abdominal drainage and seroma formation in DIEP/MS-TRAM free flap breast reconstruction patients.

Timeline

Start
2022-02-01
Primary completion
2023-02-28
Completion
2023-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator ARTISS Protein / enzyme biologic 4 ml Topical

Indications